Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease

British Journal of Surgery

Volumn 104, Issue 1, 2017, Pages 76-83

  Mazari, F A K ^a   Khan, J A ^a   Samuel, N ^a   Smith, G ^a   Carradice, D ^a   McCollum, P C ^a   Chetter, I C ^a  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOPLASTY; ANKLE BRACHIAL INDEX; COMPLICATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DUPLEX DOPPLER ULTRASONOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MALE; MULTIMODALITY CANCER THERAPY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETREATMENT; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANKLE BRACHIAL INDEX; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; MALE; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RECURRENCE; RETREATMENT; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 85008259383     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10324     Document Type: Article

References (32)

1. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384–392.
2. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329–1340.
3. Chetter IC, Scott DJ, Kester RC. An introduction to quality of life analysis: the new outcome measure in vascular surgery. Eur J Vasc Endovasc Surg 1998; 15: 4–6.
4. National Institute for Health and Care Excellence (NICE). Lower Limb Peripheral Arterial Disease: Diagnosis and Management (CG147). NICE: London, 2012.
5. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: 1425–1443.
6. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990; 4: 135–140.
7. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA et al.; Mimic Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008; 36: 680–688.
8. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996; 11: 409–413.
9. Fakhry F, Rouwet EV, den Hoed PT, Hunink MG, Spronk S. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg 2013; 100: 1164–1171.
10. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg 2010; 24: 69–79.
11. Mazari FA, Khan JA, Carradice D, Samuel N, Abdul Rahman MN, Gulati S et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg 2012; 99: 39–48.
12. Mazari FA, Khan JA, Carradice D, Samuel N, Gohil R, McCollum PT et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg 2013; 100: 1172–1179.
13. Ware JE Jr. SF-36 health survey update. Spine 2000; 25: 3130–3139.
14. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 2001; 33: 679–687.
15. Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJ. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. Br J Surg 2012; 99: 16–28.
16. Ahimastos AA, Pappas EP, Buttner PG, Walker PJ, Kingwell BA, Golledge J. A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. J Vasc Surg 2011; 54: 1511–1521.
17. Spronk S, Bosch JL, Veen HF, den Hoed PT, Hunink MG. Intermittent claudication: functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty – systematic review. Radiology 2005; 235: 833–842.
18. Muluk SC, Muluk VS, Kelley ME, Whittle JC, Tierney JA, Webster MW et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001; 33: 251–257.
19. Schmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiol 2001; 87: 3D–13D.
20. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172–1181.
21. Aquino R, Johnnides C, Makaroun M, Whittle JC, Muluk VS, Kelley ME et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg 2001; 34: 962–970.
22. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(Suppl S): S5–S67.
23. McDermott MM, Guralnik JM, Ferrucci L, Criqui MH, Greenland P, Tian L et al. Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race. J Vasc Surg 2005; 42: 1131–1137.
24. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004; 292: 453–461.
25. Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann WH et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 2015; 314: 1936–1944.
26. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.; World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124: 2458–2473.
27. Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) –the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2007; 33: 3–12.
28. Fowkes FG, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev 2000; (2)CD000017.
29. Gohil RA, Mockford KA, Mazari FA, Khan JA, Van Vanicek N, Chetter IC et al. Percutaneous transluminal angioplasty results in improved physical function but not balance in patients with intermittent claudication. J Vasc Surg 2013; 58: 1533–1539.
30. Gohil RA, Mockford KA, Mazari F, Khan J, Vanicek N, Chetter IC et al. Balance impairment, physical ability, and its link with disease severity in patients with intermittent claudication. Ann Vasc Surg 2013; 27: 68–74.
31. Giugliano G, Di Serafino L, Perrino C, Schiano V, Laurenzano E, Cassese S et al. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. Int J Cardiol 2013; 167: 2566–2571.
32. Hodges LD, Sandercock GR, Das SK, Brodie DA. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease. Clin Physiol Funct Imaging 2008; 28: 32–37.